Publications
2010
- G. Cevc, U. Vierl (2010)
Nanotechnology and the transdermal route. A state of the art review
and critical appraisal. J. Contr. Rel. 141, 277-299.
2009
- W. Kneer, I.
Rother, M. Rother, E. Seidel for the IDEA-033-III-01 Study Group (2009)
A Multiple-Dose, Open-Label, Safety, Compliance, and Usage Evaluation
Study of Epicutaneously Applied Diractin® (Ketoprofen in Transfersome®)
in Joint/Musculoskeletal Pain or Soft Tissue Inflammation. Curr. Drug
Saf. 4, 5-10.
- S. Simões, C. Marques, M. E. Cruz, M. B. Martins (2009)
Anti-inflammatory effects of locally applied enzyme-loaded ultradeformable
vesicles on an acute cutaneous model. J. Microencapsul. 26, 649-658.
- M. Rother, E. J. Seidel, P. M. Clarkson, S., Mazgareanu, U. Vierl,
I. Rother (2009)
Efficacy of epicutaneous Diractin® (ketoprofen in Transfersome®
gel) for the treatment of pain related to eccentric muscle contractions.
Drug Design, Development and Therapy 3, 143–149.
- M. M. Elsayed, U. Vierl, G. Cevc (2009)
Accurate potentiometric determination of lipid membrane-water partition
coefficients and apparent dissociation constants of ionizable drugs:
electrostatic corrections. Pharm. Res. 26, 1332-1343.
2008
- G. Cevc
Transfersomes: Innovative transdermal drug carriers. In: ‘Modified
Release Drug Delivery Technology’, 2nd revised edition (M. Rathbone,
M. Robert, J. Hadgraft, eds.) M. Dekker, New York, 2008, pp 319-332.
- G. Cevc, S. Mazgareanu,
M. Rother
Preclinical characterisation of NSAIDs in ultradeformable carriers or
conventional topical gels.Int. J. Pharm. 360, 29-39.
- G. Cevc, S. Mazgareanu,
M. Rother, U. Vierl
Occlusion effect on transcutaneous NSAID delivery from conventional
and carrier-based formulations Int. J. Pharm. 359, 190-197.
- G. Cevc, U. Vierl,
S. Mazgareanu
Functional characterisation of novel analgesic product based on self-regulating
drug carrierss. Int. J. Pharm. 360, 18-28.
- C. Wachter, U.
Vierl, G. Cevc
Adaptability and elasticity of the mixed lipid bilayer vesicles containing
non-ionic surfactant designed for targeted drug delivery across the
skin. J. Drug Targeting 16, 611-625.
2007
- G. Cevc, U. Vierl
Spatial distribution of cutaneous microvasculature and local drug clearance
after drug application on the skin. J. Contr. Rel. 118, 18-26.
- M. Rother, B.
J. Lavins, W. Kneer, K. Lehnhardt, E. J. Seidel, S. Mazgareanu.
Efficacy and safety of epicutaneous ketoprofen in Transfersome (IDEA-033)
versus oral celecoxib and placebo in osteoarthritis of the knee: multicentre
randomised controlled trial. Ann. Rheum. Dis. 66, 1178-1183.
- W. Kneer, K.
Lehnhardt, E. J. Seidel, M. Rother, S. Mazgareanu
Innovative lokale Schmerztherapie mit Diractin® (Ketoprofen in Transfersom®)
zur Behandlung der Kniegelenkarthrose. Orthop. Praxis. 43, 649-654.
2005
- S. I. Simões,
J. M. Tapadas, C.M. Marques, M. E. M. Cruz, M. B. F. Martins, G, Cevc.
(2005)
Permeabilisation and solubilisation of soybean phosphatidylcholine
bilayer vesicles, as membrane models, by polysorbate, Tween 80. Eur.
J. Pharm. Sci. 26, 307-317.
- S. I. Simões,
T. C. Delgado, R. M. Lopes, S. Jesus, A. A. Ferreira, J. A. Morais,
M. E. Cruz, M. L. Corvo, M. B. Martins
Developments in the rat adjuvant arthritis model and its use in therapeutic
evaluation of novel non-invasive treatment by SOD in Transfersomes.
J. Contr. Rel. 103, 419-434.
2004
- S. I. Simões,
C. M.Marques, M. E. M. Cruz, G. Cevc, M. B. F. Martins
Cholate effect on solubilisation and permeability of simple and protein
loaded phosphatidylcholine / sodium cholate mixed aggregates designed
to mediate macromolecules transdermal delivery. Eur. J. Pharm. Biopharm.
58, 509-519.
- G.
Cevc (2004)
Lipid vesicles and other colloids as drug carriers on the skin. Advanced
Drug Delivery Reviews, 56, 675– 711.
- G.Cevc,
G.Blume (2004)
Hydrocortisone and dexamethasone in ultra-deformable drug carriers,
Transfersomes®, have an increased biological potency and reduced therapeutic
dosages. Biochim. Biophys. Acta 1663, 61-73
2003
- G. Cevc, A.Schätzlein,
H. Richardsen, U. Vierl
Overcoming semi-permeable barriers, such as the skin, with ultradeformable
mixed lipid vesicles, Transfersomes®, liposomes or mixed lipid micelles.
Langmuir, 19, 10753-10763.
- H.
Fesq, J. Lehmann, A. Kontny, I. Erdmann, K . Theiling, M. Rother, J.
Ring, G. Cevc and D. Abeck
Improved risk-benefit ratio for topical triamcinolone acetonide in Transfersome
in comparison with equipotent cream and oinment: a randomized controlled
trial. Therapeutics; British Journal of Dermatology; 149; 611 - 619.
- G.
Cevc, G. Blume
Biological Activity and Characteristics of Triamcinolone-Acetonide formulated
with the self-regulating Drug Carriers, Transfersomes® . Biochim.
Biophys. Acta 1614:156-164.
- G. Cevc, D. Gebauer
Hydration driven transport of deformable lipid vesicles through fine
pores and the skin barrier. Biophys. J. 84: 1010-1024.
- G.
Cevc
Transdermal drug delivery of insulin with ultradeformable carriers,
Transfersomes®. Clinical Pharmacokinetics 42: 461-474.
2002
- G. Cevc
Transfersomes® - Innovative Transdermal Drug Carriers. In: Modified
Release Drug Delivery Technology. (M. Rathbone, M. Robert, J. Hadgraft,
eds.) M. Dekker, New York, pp 533-546.
- G. Cevc, A. Schätzlein,
H. Richardsen
Ultradeformable Lipid Vesicles Can Penetrate the Skin and other Semi-Permeable
Barriers Intact. Evidence from Double Label CLSM Experiments and Direct
Size Measurements. Biochim. Biophys. Acta 1564:21-30.
2001
- G. Cevc, G. Blume
New, highly efficient formulation of diclofenac for the topical,
transdermal administration in ultradeformable drug carriers, Transfersomes.
Biochim. Biophys. Acta 1514:191-205.
- J. Lehmann, S. Nissen-Meyer,
S. Paul, M. Klede, A. Ikoma, M. Schmelz, M. Rother, G. Cevc
Dermal tolerance and safety of an IFN alpha Transfersome® formulation.
In: Skin and Environment - Perception and Protection. Proceedings of
10th EADV Congress, Munich. (J. Ring, S. Weidinger, U. Darsow, eds.)
Monduzzi Editore, Bologna, 2001, pp:1031-1035.
1999
- G. Cevc
Overcoming the Skin Barrier with Artificial Smart Carriers of Drugs.
In: Intelligent Materials for Controlled Release Technologies. (S.M.
Dinh and J. DeNuzzio, A. R. Comfort, eds.) ACS Books, Washington, DC,
pp 70-86.
- H. Fesq, P. Hutzler, H. Richardsen, G. Cevc, J. Ring, D. Abeck
Detection of transepidermal intercluster gaps in human epidermis with
the help of highly deformable lipid vesicles (Transfersomes) and confocal
laser scanning microscopy. Arch. Dermatol. Res. 291, 130.
- G. Cevc, H. Richardsen
Lipid vesicles and membrane fusion. Adv. Drug. Delivery Rev. 38, 207-232.
1998
- A. Paul, G. Cevc,
B. K. Bachhawat
Transdermal Immunization With Large Membrane Bound Molecules, Gap
Junction Proteins, by Means of Ultradeformable Drug Carriers. Vaccine,
16, 188-195.
- G. Cevc, D. Gebauer,
A. Schätzlein, G. Blume
Ultraflexible Vesicles, Transfersomes, Transfersomes, Have an Extremely
Low Permeation Resistance and Transport Therapeutic Amounts of Insulin
Across the Intact Mammalian Skin. Biochim. Biophys. Acta 1368, 201-215.
- A. Schätzlein,
G. Cevc
Non-uniform cellular packing of the stratum corneum and permeability
barrier function of intact skin: a high-resolution confocal laser scanning
microscopy study using highly deformable vesicles (Transfersomes). Br.
J. Dermatol. 138, 583-592.
1997
- G. Cevc
Drug Delivery Across the Skin. Exp. Opin. Invest. Drugs, 6, 1887-1937.
- G. Cevc, G. Blume,
A. Schätzlein
Transfersomes Mediated Transepidermal Delivery Improves the Regio-Specificity
and Biological Activity of Corticosteroids in vivo. J. Contr. Rel. 45,
21, 1-226.
1996
- G. Cevc, G. Blume,
A. Schätzlein, D. Gebauer, A. Paul
The skin: a pathway for the systemic treatment with patches and
lipid-based agent carriers. Adv. Drug Del. Rev. 18, 349-378.
- G. Cevc
Lipid Suspensions on the Skin. Permeation Enhancement, Vesicle Penetration
and Transdermal Drug Delivery. Crit. Rev. Therap. Drug Carrier Systems.
13, 257-388.
1995
- G. Cevc
Material Transport Across Permeability Barriers by Means of Lipid
Vesicles. In: Handbook of Biological Physics. (Series ed. A. V. Hoff,
Volume eds. R. Lipowsky, E. Sackmann), Vol. I, North-Holland, Chapter
9, pp 465-490.
- A. Paul, G. Cevc
Non-Invasive Administration of Protein Antigens. Epicutaneous Immunization
with the Bovine Serum Albumin. Vaccine Res. 4, 145-164.
- G. Cevc, A. Schätzlein,
G. Blume
Transdermal drug carriers: basic properties, optimization and transfer-efficiency
in the case of epicutaneously applied peptides. J. Contr. Rel. 36, 3-16.
- G. Gompper, D.M.
Kroll
Driven transport of fluid vesicles through narrow pores. Phys. Rev.
E 52, 4198-4208.
- A. Paul, G. Cevc,
B. K. Bachhawat
Transdermal Immunization With Large Proteins by Means of Ultradeformable
Drug Carriers. Eur. J. Immunol. 25, 35221-3524.
- A. Schätzlein,
G. Cevc
Skin penetration by phospholipid vesicles, transfersomes, as visualized
by means of the confocal laser scanning microscopy. In: Phospholipids:
Characterization, Metabolism and Novel Biological Applications (G. Cevc,
F. Paltauf, eds.) AOCS Press, Champain, IL, pp 191-209.
1993
- G. Cevc
Dermal Insulin. In: Frontiers in Insulin Pharmacology (M. Berger,
and F. A. Gries, eds.), G. Thieme Verlag, Stuttgart, pp 161-169.
- G. Cevc, A. Schätzlein,
D. Gebauer, G. Blume
Ultra-high efficiency of drug and peptide transfer through the intact
skin by means of novel drug-carriers, Transfersomes. In: Prediction
of Percutaneous Penetration. (Bain, K. R., Hadgkraft, J., W. J. James,
K. A. Water, eds.), STS Publishing, Cardiff, Volume 3b, pp 226-234.
1992
- G. Cevc, G. Blume
Lipid vesicles penetrate into intact skin owing to the transdermal
osmotic gradients and hydration force. Biochim. Biophys. Acta 1104,
226-232.
- P. Gonzalez,
M. E. Planas, L. Rodriguez, S. Sanchez, G. Cevc
Noninvasive, percutaneous induction of topical analgesia by a new
type of drug carriers and prolongation of the local pain-insensitivity
by analgesic liposomes. Anesth. Analg. 95, 615-621.
- G. Cevc
Rationale for the Production and Dermal Application of Lipid Vesicles.
In: Liposome Dermatic. (O. Braun-Falco, H.C. Korting, H.I. Maibach,
eds.) Springer, Berlin, pp 82-90.
<---- |
Home |
About us |
Corporate Factsheet |
Science |
Publications |
Product opportunities |
Finance |
Press releases |
Latest newsletter |
Press clippings |
Conferences |
Career |
Contact |
Scientific FAQ |
Glossary |
Site Map |
Search |